Axsome Therapeutics Inc. (19X)
XSTU
Real-time Data
06:00 AM
Day's Range
153.8052 wk Range
101.20Profile - 19X - Axsome Therapeutics Inc.
Profile
Mic Code
XSTU
Sector
Healthcare
Industry
Biotechnology
Employees
1.34K
Axsome Therapeutics Inc. is a biopharmaceutical company focused on developing and commercializing therapies for central nervous system disorders. Its marketed products include Auvelity for major depressive disorder, Sunosi for excessive daytime sleepiness related to narcolepsy or obstructive sleep apnea, and Symbravo for the acute treatment of migraine. The company also maintains a neuroscience pipeline spanning additional neurological and psychiatric conditions, reflecting its emphasis on disorders with limited treatment options. Axsome Therapeutics Inc. plays a specialized role in the healthcare market by combining commercial products with ongoing clinical development in psychiatry, sleep medicine, pain, and migraine care. Based in New York, the company is positioned as a focused CNS innovator serving patients, physicians, and healthcare systems with therapies designed to address unmet medical needs.
Profile Details
Type
Common Stock
Address
One World Trade Center
City
New York
State
NY
Zip
10007
Country
United States
Phone
212 332 3241
Cross Listings - 19X - Axsome Therapeutics Inc.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
